Abstract: The present technology provides methods for treating (wet or dry) age-related macular degeneration (AMD). In particular, the present technology relates to the use of elamipretide, or a pharmaceutically acceptable salt thereof, in effective amounts to treat (wet or dry) age-related macular degeneration (AMD) and thereby decrease the rate of growth of photoreceptor loss over time in a subject, such as a mammal (e.g., a human).

Abstract: The present technology provides methods and compositions for treating, preventing and/or delaying (slowing) the progression of age-related macular degeneration (AMD). In particular, the present technology relates to the use of elamipretide in effective amounts to treat, prevent and/or delay (slow) the progression of photoreceptor loss, AMD, GA secondary to AMD, non-exudative (dry) age-related macular degeneration, intermediate age-related macular degeneration, age-related macular degeneration with photoreceptor loss or non-exudative (dry) age-related macular degeneration with photoreceptor loss in mammalian subjects.

Abstract: The disclosure provides methods of preventing or treating Sengers syndrome in a mammalian subject, reducing risk factors associated with Sengers syndrome, and/or reducing the likelihood or severity of Sengers syndrome. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to increase expression of AGK in subjects in need thereof.

Abstract: The disclosure provides methods of preventing or treating Sengers syndrome in a mammalian subject, reducing risk factors associated with Sengers syndrome, and/or reducing the likelihood or severity of Sengers syndrome. The methods comprise administering to the subject an effective amount of an aromatic-cationic peptide to increase expression of AGK in subjects in need thereof.

Abstract: A self-adhesive label for a bottle, such as a pharmaceutical stock bottle, comprises an adhesive layer and a release-liner. An adhesive section and a detachable section are die cut into the adhesive layer. The adhesive and detachable sections are removably attached to a release-liner which is coated with a non-stick composition. The detachable section is superimposed on a portion of the release-liner which is larger than the detachable section but smaller than the adhesive section. When the adhesive layer is separated from the release liner and adhered to a first surface, the detachable section of the adhesive layer remains under the detachable section. The first surface may be a pharmacist's stock bottle. Thus, the detachable section (e.g., a sticker containing useful information for a patient) may be detached from the balance of the label and adhered to second surface, such as the surface of a patient's bottle.